Recent Finacing
Recent Raise
Design Pharmaceuticals operates an ultrahigh-throughput drug-discovery platform that combines cell-free biosynthesis and microfluidics to biomine structurally diverse natural molecules from microbiota and screen them across hundreds of GPCR targets.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor